POINT Biopharma Global Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Dec 23 | SellUS$3,437,408 | BVF Partners L.P. | Company | 276,097 | US$12.45 | |
18 Dec 23 | SellUS$213,657,911 | BVF Partners L.P. | Company | 17,161,278 | US$12.45 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,760,324 | 3.53% |
Individual Insiders | 15,338,740 | 14.4% |
General Public | 35,801,120 | 33.6% |
Institutions | 51,669,047 | 48.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,727,975 | US$109.1m | -5.42% | no data | |||
6,635,892 | US$82.9m | 4.5% | no data | |||
4,667,786 | US$58.3m | 4.77% | no data | |||
3,757,700 | US$47.0m | 0% | no data | |||
3,527,235 | US$44.1m | 3.86% | no data | |||
3,496,313 | US$43.7m | -3.32% | no data | |||
3,006,574 | US$37.6m | -7.68% | no data | |||
2,909,960 | US$36.4m | -3% | 5.89% | |||
2,781,565 | US$34.8m | 0% | 1.17% | |||
2,500,000 | US$31.2m | 0% | 1.37% | |||
2,351,160 | US$29.4m | 87.2% | 0.32% | |||
2,157,166 | US$27.0m | -12.1% | 0.03% | |||
1,900,074 | US$23.8m | 10.1% | no data | |||
1,613,516 | US$20.2m | 24.2% | 0.95% | |||
1,106,042 | US$13.8m | 15% | 0.03% | |||
1,000,000 | US$12.5m | 0% | 0.29% | |||
995,217 | US$12.4m | -10.2% | no data | |||
952,642 | US$11.9m | 0% | 2.44% | |||
851,735 | US$10.6m | 0% | 0.01% | |||
822,026 | US$10.3m | 2.6% | no data | |||
794,611 | US$9.9m | 110% | 0.01% | |||
789,100 | US$9.9m | -61.8% | 0.02% | |||
772,905 | US$9.7m | 0% | 0.65% | |||
732,936 | US$9.2m | -16.6% | 1.34% | |||
689,179 | US$8.6m | 184% | no data |